Iago Rodríguez-Lago 1, José Manuel Benítez 2, Valle García-Sánchez 2, Ana Gutiérrez 3, Laura Sempere 4, Daniel Ginard 5, Manuel Barreiro-de Acosta 6, José Luis Cabriada 7 , Gastroenterol Hepatol. Aug-Sep 2018;41(7):423-431.
Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view.
Granulocyte and monocyte apheresis is well tolerated and accepted by patients with IBD. Although we found no significant differences according to type of IBD or apheresis regimen, patient perception was affected by clinical effectiveness.
Crohn's disease / Leukocytapheresis / patient / QoL / Safety / ulcerative colitis /
Contact UsFor more informationContact Us